Mode
Text Size
Log in / Sign up

Multifaceted preventive nursing program reduces fall incidence from 19.8% to 7.1% in elderly NHL patientsNursing Program Reduces Fall Risk for Lymphoma Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider implementing multifaceted nursing programs to reduce fall incidence in elderly patients with non-Hodgkin's lymphoma.

This randomized controlled trial enrolled 210 older adults (age >= 65 years) with newly diagnosed or relapsed non-Hodgkin's lymphoma requiring chemotherapy. The study compared a multifaceted preventive nursing program based on individualized risk assessment against standard oncology nursing over a 12-week follow-up period.

The primary outcome was fall incidence and recurrence. The intervention group showed a significantly lower fall incidence of 7.1% compared to 19.8% in the control group (p = 0.012). Secondary outcomes indicated that patients in the intervention group experienced fewer severe injuries, better chemotherapy adherence, improved functional mobility on the Timed Up and Go test, and higher quality of life scores.

Safety data regarding adverse events or discontinuations were not reported. The study was limited by its single-center design. These results suggest that integrating specific fall prevention measures into routine oncology nursing may improve safety and treatment adherence for elderly patients with non-Hodgkin's lymphoma.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in supportive care for non-Hodgkin's lymphoma by providing evidence on fall prevention. While previous coverage noted higher cancer-related mortality in solid organ transplant recipients with non-Hodgkin's lymphoma, this study focuses on improving safety and treatment continuity during active chemotherapy. It does not relate to the IL-10 rs1800890 variants or CAR-T cell exhaustion strategies previously reported.

Researchers conducted a randomized controlled trial to see if a specific nursing program could help older adults with non-Hodgkin's lymphoma. The study included 194 patients aged 65 and older who were undergoing chemotherapy. These patients received either standard oncology nursing or a multifaceted preventive nursing program based on individual risk assessments.

The results showed that the specialized nursing group had much lower fall rates, with only 7.1% of patients falling compared to 19.8% in the standard care group. Patients in the special program also reported fewer severe injuries, better chemotherapy adherence, and improved mobility scores. They also reported a higher quality of life.

Because this was a single-center study, the results should be viewed with some caution. While the trial showed a clear link between the nursing program and safer outcomes, more studies across different locations are needed to confirm these findings for all patients.

What this means for you:
A specialized nursing program significantly reduced falls and improved mobility for older lymphoma patients.

Common questions

Who can benefit from this nursing program?

This program was specifically studied in older adults aged 65 and over who were newly diagnosed with or had relapsed non-Hodgkin's lymphoma. These patients were undergoing chemotherapy as part of their treatment plan.

How did the program affect fall rates?

The study found a significant difference in falls between groups. Only 7.1% of patients in the nursing program group fell, compared to 19.8% of those receiving standard oncology nursing.

Did the program improve other parts of treatment?

Yes, patients in the intervention group showed better chemotherapy adherence and improved functional mobility scores on the Timed Up and Go test. They also reported higher quality of life scores than those receiving standard care.

Study Details

Study typeRct
Sample sizen = 210
EvidenceLevel 2
Follow-up780.0 mo
PublishedJul 2026
View Original Abstract ↓
BACKGROUND: Non-Hodgkin's lymphoma (NHL) is a diverse group of lymphoproliferative malignancies that predominantly affects older adults. Chemotherapy remains the primary modality of treatment for many NHL subtypes, yet it often brings about adverse effects such as myelosuppression, anemia, and neuropathy, all of which contribute to a heightened risk of falls in older patients. Falls in this population can lead to serious complications, including fractures and intracranial injuries, thereby impacting functional status and potentially delaying oncological treatment. OBJECTIVE: This study was aimed at assessing the efficacy of a structured, evidence-based preventive nursing protocol in reducing falls among older patients with NHL undergoing chemotherapy compared to standard care. METHODS: A prospective, single-center randomized controlled trial enrolled 210 older patients (≥ 65 years) newly diagnosed with or relapsed NHL requiring chemotherapy. Participants were randomly assigned to an Intervention Group-receiving a multifaceted preventive nursing program based on individualized risk assessment-or a Control Group that received standard oncology nursing. Primary outcomes included fall incidence and recurrence. Secondary outcomes encompassed fall-related injuries, Timed Up and Go (TUG) test performance, chemotherapy completion, and quality of life. Statistical analyses were conducted using SPSS 27.0 with significance set at p < 0.05. RESULTS: Of 210 participants enrolled, 194 (98 in the Intervention Group and 96 in the Control Group) completed the 12-week follow-up. The Intervention Group demonstrated a significantly lower fall incidence (7.1%) compared with the Control Group (19.8%, p = 0.012). Patients in the Intervention Group had fewer severe injuries, better chemotherapy adherence, improved functional mobility as measured by TUG tests, and higher quality of life scores. CONCLUSION: A targeted, multifactorial nursing intervention substantially reduced falls and fall-related complications among older adults with NHL receiving chemotherapy. Integration of fall prevention measures into routine oncologic care is strongly recommended to safeguard treatment continuity and patient well-being. Further multicenter and long-term studies are warranted to validate these findings and refine comprehensive fall prevention strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.